Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy

Published:2018 Issue:5 Volume:94 Page:223
ISSN:2288-6575
Container-title:Annals of Surgical Treatment and Research
language:en
Short-container-title:Ann Surg Treat Res

Author:

Lee Jihyoun¹,Lee Jong Eun²,Kim Zisun³,Han Sun Wook²,Hur Sung Mo³,Kim Sung Yong²,Lee Min Hyuk¹,Lim Cheol Wan³^ORCID

Affiliation:

1. Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea.

2. Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.

3. Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Publisher

The Korean Surgical Society

Subject

Surgery

Link

https://synapse.koreamed.org/pdf/10.4174/astr.2018.94.5.223

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer;The Breast;2023-12

2. COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim;Journal of Clinical Medicine;2022-11-29

3. Evaluating the safety and effectiveness of PegaGen® (pegfilgrastim) for the prevention of chemotherapy-induced febrile neutropenia: a post-marketing surveillance study;Supportive Care in Cancer;2022-07-06

4. Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors;JAMA Network Open;2022-01-27

5. Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy;Journal of Chemotherapy;2021-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3